Invention Grant
- Patent Title: Fatty acid synthase inhibitors
-
Application No.: US15259363Application Date: 2016-09-08
-
Publication No.: US09725437B2Publication Date: 2017-08-08
- Inventor: Cynthia Ann Parrish
- Applicant: GlaxoSmithKline Intellectual Property (No.2) Limited
- Applicant Address: GB Brentford, Middlesex
- Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
- Current Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
- Current Assignee Address: GB Brentford, Middlesex
- Agent Wayne J. Dustman; Edward R. Gimmi
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/4709 ; A61K45/06
Abstract:
This invention relates to triazolones and triazolones for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of triazolones in the treatment of cancer.
Public/Granted literature
- US20160376257A1 FATTY ACID SYNTHASE INHIBITORS Public/Granted day:2016-12-29
Information query
